Zargari, Arezou,Admyre, Charlotte,Sandwall, Pernilla,Knittel, Thomas,Zerhouni, Peter
申请号：
AU2018265211
公开号：
AU2018265211A1
申请日:
2018.05.09
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention provides an oligonucleotide comprising the sequence 5'-GGAACAGTTCGTCCATGGC-3' (SEQ ID NO:2) for use in the treatment of inflammatory bowel disease in a human subject, wherein individual doses of from 150mg to 350mg of said oligonucleotide are administered to the subject on at least two separate occasions, wherein said separate occasions are 3 weeks apart.
